Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Woolson Insider Profile
4 Followers
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical, holds 13.11K shares in ICU Medical (Ticker: ICUI). Most recently, Daniel Woolson Sold $2,502 shares of ICU Medical on Aug 30, 2024 for an estimated value of 408.35K.
Daniel Woolson ICU Medical (ICUI)VP, GM-Infusion Capital
ICU Medical (ICUI)
VP, GM-Infusion Capital
Ranked #86,475 out of 99,218 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-36.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
VP, GM-Infusion Capital
Roles that Daniel Woolson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Woolson
Daniel Woolson's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Woolson's performance on stock
You May Also Like
Daniel Woolson insider profile FAQ
What is the percentage of profitable transactions made by Daniel Woolson?
The percentage of profitable transactions made by Daniel Woolson is 25%.
What is the average return per transaction made by Daniel Woolson?
The average return per transaction made by Daniel Woolson is -36.70%.
What stocks does Daniel Woolson hold?
Daniel Woolson holds: ICUI stocks.
What was Daniel Woolson’s latest transaction?
Daniel Woolson latest transaction was an Informative Sell of $408.35K.
What was Daniel Woolson's most profitable transaction?
Daniel Woolson’s most profitable transaction was an Informative Sell of ICUI stock on May 24, 2018. The return on the trade was 17.30%.
What is Daniel Woolson's role in ICU Medical?
Daniel Woolson's role in ICU Medical is VP, GM-Infusion Capital.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.